Oncology medicine spending is rising quickly. Over a five-year period, spending is expected to grow almost 75%.
According to recent data, global spending on cancer medicines was about $252 billion in 2024 and is expected to reach around $441 billion by 2029.
Let’s examine the causes for the spending increase below. Read More >
VytlOne offers hospital systems proven solutions for optimizing pharmacy services’ positive impact on the continuum of care; solutions ranging from management of 340B prescription-savings programs, Retail and Specialty Pharmacy operations, to Prescription Benefits program management, patient financial assistance and Readmission Reduction programs.
This post is related to:
